Literature DB >> 27769109

Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Kangkana Kataki1,2, Parikhit Borthakur1, Namrata Kumari1, Manab Deka1, Amal Ch Kataki2, Subhash Medhi1.   

Abstract

During Hepatitis B virus infection, the pathogen sensors Toll-like receptors (TLRs) play a role in innate immunity system. The study aimed to investigate mRNA expression levels of TLR2 and TLR3 in Hepatitis B virus (HBV) mediated chronic hepatitis B (CHB), cirrhosis (CIRR), and hepatocellular carcinoma (HCC), and to correlate viral load with severity of these diseases and expression of TLRs. A total of 180 HBV DNA positive samples were selected for the study. HVB-DNA was detected by multiplex PCR. Viral load estimation was done by using the Ampisure HBV Quantitative kit as per manufacture instructions. Expression levels of TLR2 and TLR3 were determined by real time PCR. The viral load was estimated to be 6.64log10 IU/ml in CHB, 4.88log10 IU/ml in CIRR, and 4.86log10 IU/ml in HCC. No significant association of viral load was found with increasing age. Upregulation of TLR2 expression in CHB when individually compared with CIRR and HCC was found to be statistically significant. Downregulation of TLR3 expressions in CIRR when compared to both CHB and HCC individually were found to be statistically significant. No significant effect of viral load on the expression of TLR2 and 3 were found. With severity of the disease from CHB to HCC, the HBV load decreases. The study suggests the possibility of HBV interacting with signalling of both analysed TLR receptors which partially explains the induction of immune tolerance pathways by Hepatitis B virus. J. Med. Virol. 89:1008-1014, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHB; CIRR; HCC; Hepatitis B virus; innate immunity; toll-like receptor

Mesh:

Substances:

Year:  2017        PMID: 27769109     DOI: 10.1002/jmv.24719

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population.

Authors:  Janett Fischer; Eleni Koukoulioti; Eckart Schott; Balazs Fülöp; Renate Heyne; Thomas Berg; Florian van Bömmel
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

2.  Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases.

Authors:  Liang Duan; Qianfan Yang; Jun Yang; Qin Hu; Bo Wang; Pu Li; Weixian Chen
Journal:  J Transl Med       Date:  2018-09-29       Impact factor: 5.531

3.  Toll-like receptors, long non-coding RNA NEAT1, and RIG-I expression are associated with HBeAg-positive chronic hepatitis B patients in the active phase.

Authors:  Yongbin Zeng; Wennan Wu; Ya Fu; Shanjian Chen; Tianbin Chen; Bin Yang; Qishui Ou
Journal:  J Clin Lab Anal       Date:  2019-03-29       Impact factor: 2.352

4.  In situ self-assembly of Au-antimiR-155 nanocomplexes mediates TLR3-dependent apoptosis in hepatocellular carcinoma cells.

Authors:  Liang Yin; Weijuan Cai; Yongqian Liang; Jie Yao; Xuemei Wang; Jie Shen
Journal:  Aging (Albany NY)       Date:  2020-11-05       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.